[Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque...

Area of Science:

• Cardiology
• Vascular Biology
• Pharmacology

Background:

• Atherosclerotic vascular disease involves inflammation and lipid accumulation, driven by risk factors like dyslipidemia.
• Vulnerable plaques, prone to rupture and causing acute coronary syndromes, are characterized by lipid content, inflammation, cap strength, apoptosis, necrosis, and neovascularization.
• Patient risk profiles influence plaque vulnerability.

Purpose of the Study:

• To review studies on the plaque-stabilizing effects of atorvastatin.
• To highlight atorvastatin's role in preventive cardiology.

Main Methods:

• Literature review of studies investigating atorvastatin's impact on atherosclerotic plaque characteristics.
• Analysis of data on lipid-lowering and pleiotropic effects of atorvastatin.

Main Results:

• Atorvastatin treatment leads to more stable atherosclerotic plaques.
• Stabilization of plaques by atorvastatin is associated with a reduction in cardiovascular events.
• Statins, including atorvastatin, exert beneficial effects through lipid reduction and pleiotropic actions.

Conclusions:

• Atorvastatin demonstrates significant plaque-stabilizing properties.
• Stabilizing atherosclerotic plaques with atorvastatin is a crucial strategy in preventing cardiovascular events.
• The findings support the use of atorvastatin in managing atherosclerotic vascular disease.